Therapeutic Intervention Code in a Cognitive Geriatric Unit
NCT ID: NCT03408028
Last Updated: 2018-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
310 participants
OBSERVATIONAL
2017-04-01
2017-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Most hospitals and care institutions have developed codes, in multidisciplinary internal consultation, to address the interruption or lack of implementation of treatments that make no sense from a medical point of vue. This avoids therapeutic relentlessness.The code in place within the CHU Brugmann is:
* code A: no therapeutic restriction
* code B: not to be resuscitated
* code C: not to be intensively treated (no escalation in therapeutic treatments)
* code D: best palliative care (progressive de-escalation in therapeutic treatments).
These codes are established in consultation with the patient or his legal representative and are re-evaluated in a multidisciplinary way every week.
Planning a care path and therefore establishing a therapeutic code is particularly important for people with cognitive impairment and dementia because the progressive loss of cognitive abilities complicates the process of decision making.
A large part of the admissions are made via the emergency department. For these patients, no therapeutic plan has been established beforehand. However, the perception of the functional and cognitive status of the patient directly influences the intensity of care provided. Cognitive disorders are a risk factor for the exclusion of access to palliative care for the elderly patient.
The objectives of this study are:
* To establish a record of the therapeutic limitation codes in an acute cognitive geriatric unit
* To correlate the therapeutic limitation code with the comorbidities of the patients
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating an In-home Multicomponent Program to Manage Concerns About Falling in Frail Community Dwelling Older People
NCT01358032
Guidance for Elderly With Cognitive Disorders
NCT01076855
Efficacy of a Multidomain Intervention on Lifestyle Risk Factors for Dementia Prevention
NCT06748625
Home-based Cognitive Treatment and Cognitive Impairment
NCT04889560
Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults with Cognitive Deficits
NCT06888713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive impairment
Geriatric patients with a cognitive impairment
Medical File consultation
Medical File consultation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical File consultation
Medical File consultation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Murielle Surquin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Murielle Surquin
Head of Clinic
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolina Natalia Grande Pérez, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Brugmann
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Brugmann
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUB- status code
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.